Overview

* Cypherpunk Technologies reports Q3 net loss of $3.3 mln, down from $18.2 mln last year

* Company acquires 203,775 ZEC for $50 mln as part of digital asset strategy

* Closed $58.88 mln private placement led by Winklevoss Capital for digital asset strategy

Outlook

* Company did not provide specific financial guidance for future quarters or year

Result Drivers

* DIGITAL ASSET STRATEGY - Co established a digital asset treasury strategy focused on Zcash, acquiring over 203,775 ZEC for $50 mln

* CLINICAL TRIAL RESULTS - Co presented final data from Phase 2 trial of sirexatamab in CRC patients, showing significant benefits

* PRIVATE PLACEMENT - Co closed $58.88 mln private placement led by Winklevoss Capital to fund digital asset strategy

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Net -$3.30

Income mln

Analyst Coverage

* The one available analyst rating on the shares is "hold"

* The average consensus recommendation for the biotechnology & medical research peer group is "buy."

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)